• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syschem (India) Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 6001.0
  • ISIN : INE121D01036
36.13 -1 (-2.43%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    35.55

  • Today’s High

    37.99

  • Open

    36.70

  • Perv Close

    37.03

  • 52W Low

    28.81

  • 52W High

    60.95

Key Indicators

  • P/E(TTM)

    31.42

  • Mar.Cap (₹Cr.)

    193.71

  • Div & Yield %

    0.00

  • Book Value(₹)

    26.86

  • Debt-Equity Ratio

    -2.43

  • AGM Date

    29-Sep-2026

  • EPS

    1.15

  • P/E Ratio

    31.42

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    193.71

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    53.62

  • BV (₹)

    26.90

  • Sales( ₹ in Cr.)

    654.63

  • NP (in Cr.)

    10.93

  • NP Var(%)

    2259.0

  • Div%

    0.0

  • CPS (₹)

    2.80

  • EPS (₹)

    2.00

  • Traded Value (₹ in Lakhs)

    193.71

  • 52 Week High

    60.95

  • 52 Week Low

    28.81

  • Price BSE

    36.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    193.71

  • P/C Ratio

    12.90

  • P/E Ratio

    17.70

  • Price Vs.BV

    2.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 654.63 386.23 233.48 130.38 65.63 74.41
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 654.63 386.23 233.48 130.38 65.63 74.41
Other Income 0.02 0.04 0.17 0.25 0.13 0.26
Stock Adjustments -14.49 3.65 22.25 -1.12 0.88 -5.44
Total Income 640.16 389.92 255.90 129.51 66.64 69.23
EXPENDITURE :            
Raw Materials 508.58 310.87 197.91 92.46 46.97 55.42
Power and Fuel Cost 5.78 2.90 2.84 2.15 2.39 2.87
Employee Cost 10.36 8.25 6.08 4.40 4.54 4.10
Other Manufacturing Expenses 5.46 5.19 4.35 2.95 3.46 2.92
Selling and Administration Expenses 88.13 58.29 37.32 18.30 8.41 8.47
Miscellaneous Expenses 0.74 0.40 0.25 0.35 0.18 0.36
Employee Benefit Expenses 10.36 8.25 6.08 4.40 4.54 4.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 619.05 385.90 248.75 120.61 65.95 74.14
Operating Profit 21.11 4.03 7.15 8.89 0.69 -4.90
Interest 2.26 0.07 0.25 0.04 0.28 0.06
Gross Profit 18.85 3.96 6.90 8.85 0.41 -4.96
Depreciation 4.06 2.95 2.79 2.70 2.58 2.35
Profit Before Tax 14.79 1.01 4.11 6.15 -2.17 -7.31
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.86 0.55 1.35 1.64 -0.47 -1.75
Reported Net Profit 10.93 0.46 2.76 4.51 -1.71 -5.57
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -0.28
Adjusted Net Profit 10.93 0.46 2.76 4.51 -1.71 -5.29
Adjustment below Net Profit 0.00 0.00 0.00 0.12 0.00 0.00
P & L Balance brought forward -10.64 -11.10 -13.87 -18.50 -16.79 -11.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.28 -10.64 -11.10 -13.87 -18.50 -16.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.23 0.11 0.69 1.42 -0.73 -2.58
Earnings Per Share(Adj)-Unit Curr 2.23 0.11 0.69 1.30 -0.67 -2.37
Book Value 24.98 20.98 14.29 6.99 2.60 2.79
Book Value(Adj)-Unit Curr 24.98 20.98 14.29 6.42 2.39 2.56

Shareholding Pattern

  • Promoter Group

    63.38%

  • Public Share Holding

    36.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 33,983,610 63.38 29,631,110 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 33,983,610 63.38 29,631,110 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 80,000 0.15 80,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 80,000 0.15 80,000 1
2] Non Institution
Bodies Corporate 2,868,727 5.35 2,837,627 90
Clearing Members 50,479 0.09 50,479 16
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 353,316 0.66 200,616 269
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,172,141 2.19 1,172,141 248
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,062,716 15.04 8,062,716 104
Individuals holding nominal share capital up to Rs. 1 lakh 6,870,788 12.81 6,772,186 12,069
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 100,000 0.19 100,000 2
Sub Total 19,551,890 36.47 19,269,488 12,811
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 53,615,500 100.00 48,980,598 12,825

Company Background

Syschem (India) LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Syschem (India) Ltd
  • BSE Code : 6001.0
  • ISIN : INE121D01036

  • Incorporation Year

    1993

  • Registered Office

    Tehsil Kalka
    Bargodam Village, Panchkula,
    Haryana-133302

  • Telephone

    91-172-3077777

  • FAX

    91-172-3077700

  • Chairman

  • Managing Director

  • Company Secretary

    Shikha Kataria

  • Auditor

    STAV & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99,
    Madangir Behind LSC,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Syschem (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syschem (India) 36.13 654.65 654.63 31.42 14.88
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77